Kaufmann G - Search Results

1

Open and hidden agendas of "asymptomatic" patients who request check-up exams.

Hunziker S, Schläpfer M, Langewitz W, Kaufmann G, Nüesch R, Battegay E, Zimmerli LU. Hunziker S, et al. Among authors: kaufmann g. BMC Fam Pract. 2011 Apr 19;12:22. doi: 10.1186/1471-2296-12-22. BMC Fam Pract. 2011. PMID: 21504617 Free PMC article.

2

Immunological recovery and antiretroviral therapy in HIV-1 infection.

Battegay M, Nüesch R, Hirschel B, Kaufmann GR. Battegay M, et al. Lancet Infect Dis. 2006 May;6(5):280-7. doi: 10.1016/S1473-3099(06)70463-7. Lancet Infect Dis. 2006. PMID: 16631548 Review.

3

Productivity costs and determinants of productivity in HIV-infected patients.

Sendi P, Schellenberg F, Ungsedhapand C, Kaufmann GR, Bucher HC, Weber R, Battegay M; Swiss HIV Cohort Study. Sendi P, et al. Clin Ther. 2004 May;26(5):791-800. doi: 10.1016/s0149-2918(04)90080-x. Clin Ther. 2004. PMID: 15220024

4

Immune reconstitution in HIV-infected patients.

Hirsch HH, Kaufmann G, Sendi P, Battegay M. Hirsch HH, et al. Among authors: kaufmann g. Clin Infect Dis. 2004 Apr 15;38(8):1159-66. doi: 10.1086/383034. Epub 2004 Apr 5. Clin Infect Dis. 2004. PMID: 15095223

5

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.

Wolbers M, Battegay M, Hirschel B, Furrer H, Cavassini M, Hasse B, Vernazza PL, Bernasconi E, Kaufmann G, Bucher HC; Swiss HIV Cohort Study. Wolbers M, et al. Among authors: kaufmann g. Antivir Ther. 2007;12(6):889-97. Antivir Ther. 2007. PMID: 17926643

6

Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals.

Elzi L, Kaufmann G, Weber R, Fux CA, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Battegay M; Swiss HIV Cohort Study. Elzi L, et al. Among authors: kaufmann g. HIV Clin Trials. 2009 Jul-Aug;10(4):207-14. doi: 10.1310/hct1004-207. HIV Clin Trials. 2009. PMID: 19723609

7

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group. Kaufmann GR, et al. Arch Intern Med. 2003 Oct 13;163(18):2187-95. doi: 10.1001/archinte.163.18.2187. Arch Intern Med. 2003. PMID: 14557216

8

Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.

Kaufmann GR, Khanna N, Weber R, Perrin L, Furrer H, Cavassini M, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study. Kaufmann GR, et al. Antivir Ther. 2004 Apr;9(2):263-74. Antivir Ther. 2004. PMID: 15134189 Clinical Trial.

9

Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes.

Hansjee N, Kaufmann GR, Strub C, Weber R, Battegay M, Erb P; Swiss HIV Cohort Study. Hansjee N, et al. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):671-7. doi: 10.1097/00126334-200406010-00003. J Acquir Immune Defic Syndr. 2004. PMID: 15167285

10

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study. Kaufmann GR, et al. Clin Infect Dis. 2005 Aug 1;41(3):361-72. doi: 10.1086/431484. Epub 2005 Jun 24. Clin Infect Dis. 2005. PMID: 16007534 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters